Product image of Feiba Nf (Factor Viii Inhibitor Bypassing Fraction) supplied by GNH India

Feiba Nf

Active Ingredient:
Factor Viii Inhibitor Bypassing Fraction
Origin:
EU

Feiba Nf (Factor Viii Inhibitor Bypassing Fraction)

Feiba NF is a Factor VIII Inhibitor Bypassing Fraction used for managing bleeding episodes in patients with hemophilia. This intravenous medication helps in clotting blood, providing essential support for those with specific clotting disorders.

Manufacturer / TM Owner

Takeda Pharma Sp. Z O.O.

1
Pack/s
This product is added to your enquiry list

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

A minimum order value applies. Our team will confirm the exact amount or quantity after reviewing your requirements.

Indications & Clinical Uses

  • Feiba NF is primarily used to manage bleeding episodes in patients with hemophilia who have developed inhibitors to Factor VIII. It is designed to help the blood clot more effectively, addressing the challenges posed by these inhibitors. This medication is crucial for individuals who experience frequent or severe bleeding due to their condition.

Side Effects

  • Feiba NF works by bypassing the need for Factor VIII, which is often deficient or inhibited in patients with hemophilia. This helps to promote clotting and reduce bleeding episodes. The effects are typically observed shortly after administration, providing rapid support for those in need.

Precautions & Warnings

  • Feiba NF should be administered under the supervision of a healthcare professional. It is important to follow the prescribed dosage and administration guidelines to ensure safety and effectiveness. Patients should be monitored for any adverse reactions, and any concerns should be promptly reported to a healthcare provider.

Avoid Interactions

  • Feiba NF may interact with other medications, particularly those that affect blood clotting. It is important to inform your healthcare provider about all medications you are taking to avoid potential interactions. Always consult with a healthcare professional before starting or stopping any medication.

Frequently Asked Questions

Feiba NF is used to manage bleeding episodes in patients with hemophilia who have developed inhibitors to Factor VIII.

Feiba NF is administered intravenously, typically under the supervision of a healthcare professional.

Common side effects may include reactions at the injection site, fever, and nausea. Always consult a healthcare provider for personalized advice.

Feiba NF may interact with other medications, so it is important to inform your healthcare provider about all medications you are taking.

Feiba NF is manufactured by Takeda Pharma Sp. Z O.O.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated:

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.

Related Products

Other formulations containing Factor Viii Inhibitor Bypassing Fraction

A

A
A

A
A

A
A

A

Browse all products →

Ordering Process

Simple, Secure, and Seamless

Learn how our streamlined ordering process guarantees fast, compliant, and reliable access to essential medicines worldwide.

Quote request form

01

Submit Quote Request Form

Tell us what medications you need by filling out our simple form and uploading a valid document.

Price estimate review

02

We Review & Send Estimate

Our licensed pharmacists will verify your details and provide you with a detailed cost estimate.

Secure payment

03

Confirm & Make Payment

Discuss any queries, approve the estimate, and complete your payment.

Worldwide delivery

04

Get Delivered

Your medicines, safely packed and delivered to your door or nearest airport — hassle-free.

Regulatory recognitions

Quality You Can Trust

Our internationally recognized certifications underscore our commitment to safety, quality, and excellence.

SGS GSDP Certification

GSDP Compliant from SGS

URS ISO 9001

URS ISO 9001 Certification

FDA Maharashtra

Licensed by FDA Maharashtra

IEC License DGFT

IEC License issued by DGFT